Niagen Bioscience Inc (NAGE) Stock Price Quote Today & Current Price Chart

Trade Niagen Bioscience Inc - NAGE

About Chromadex Corp

ChromaDex Corp. is a global bioscience company, which is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. NAD+ is a coenzyme and a regulator of cellular metabolism. It operates through three segments: Consumer products, Ingredients, and Analytical reference standards and services segment. The Consumer products segment provides finished dietary supplement products that contain the ingredients directly to consumers as well as to distributors. The Ingredients segment develops and commercializes ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Analytical reference standards and services segment supplies phytochemical reference standards and other research and development services. Its ingredients include Tru Niagen and Immulina. The Tru Niagen is a form nicotinamide riboside (NR). NR is a member of the vitamin B3 family. Immulina is a spirulina extract.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Chromadex Corp revenues increased 14% to $67.4M. Net loss increased 36% to $27.1M. Revenues reflect Consumer Products Segments increase of 20% to $56.7M, Analytical Reference Standards and Service segment increase of 12% to $3.3M. Higher net loss reflects Corporate and other segment loss increase of 19% to $36.4M, Ingredients Segments income decrease of 27% to $3.7M.

Equity composition

Common Stock $.001 Par, 08/11, 150M auth., 60,875,325 issd. Insiders & Strategic holders own 45.88%. 04/16, 1-for-3 recerse stock split.

Latest shares articles

Global financial markets with investment chart

Michael Kramer: What Would a Third Straight Hot Inflation Report Mean for Markets?

Inflation rates surged as oil prices rose. After two months of elevated CPI reports, the May reading was expected to show a further increase in the annual inflation rate, arriving one week before the June FOMC meeting.

7 hours ago

Michael Kramer: Why Do Revisions Matter So Much in the Payroll Report?

The most important number in the monthly US non-farm payroll report may not be the headline payroll figure, but the revisions that follow months later.

14:09, 16 July 2026